相关实验视频
Updated: Jan 10, 2026

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.5K
在AERD中的现实世界治疗模式:对ATAD,生物制剂和组合疗法的分析
Nitish Kumar1, Tyson Pace2, Pedro Lança Gomes1,3
1Department of Otorhinolaryngology-Head & Neck Surgery, Mayo Clinic, Phoenix, Arizona, USA.
International forum of allergy & rhinology
|November 21, 2025
概括
阿司匹林脱敏和生物药物是阿司匹林恶化呼吸系统疾病 (AERD) 的常见治疗方法. 生物药物治疗中断率低于阿司匹林脱敏治疗,年轻患者经常更换治疗方法.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿司匹林加剧呼吸系统疾病 (AERD) 是一种慢性疾病.
- 目前的治疗策略旨在控制呼吸系统症状并改善生活质量.
研究的目的:
- 分析AERD的当代治疗模式.
- 为了比较阿司匹林脱敏治疗与生物疗法的有效性和患者坚持.
主要方法:
- 对患者数据的回顾性分析.
- 治疗组间的停药率和患者人口统计数据的比较.
主要成果:
- 在55%的AERD患者中使用阿司匹林脱敏剂,而在48%的患者中使用生物药物.
- 与阿司匹林无敏化相比,生物药物中断率较低.
- 接受生物治疗的患者通常较年轻,大约25%的患者转向替代治疗.
结论:
- 与阿司匹林脱敏相比,生物药物代表了AERD更可持续的治疗选择.
- 对长期结果和患者特定治疗选择的进一步研究是有必要的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
465
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
465
Inflammatory Bowel Disease IV: Pharmacological Management
452
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
452
Therapeutic Drug Monitoring: Affecting Factors
183
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183
Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235
Therapeutic Drug Monitoring: Overview and Classification
279
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
279
Dosage Regimens: Designs and Approaches
246
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
246

